Comparative Efficacy and Safety of Pulmonary Surfactant Delivery Strategies in Neonatal RDS
Author Information
Author(s): Liu Shiyue, Wang Yu, Zhu Xingwang, Chen Feifan, Shi Yuan
Primary Institution: Children’s Hospital of Chongqing Medical University
Hypothesis
To compare five pulmonary surfactant administration strategies for neonates with respiratory distress syndrome.
Conclusion
The thin catheter strategy minimized intubation risk and showed a better composite effect in reducing both mortality and BPD incidence.
Supporting Evidence
- LMA and LISA significantly reduced intubation rates compared to usual care.
- SN had a higher intubation rate compared to LISA and LMA.
- LMA had a higher incidence of BPD compared to LISA.
- SN ranked second to LISA in preventing BPD and death.
- Most results were rated as low or very low quality.
Takeaway
This study looked at different ways to give medicine to help babies breathe better when they are born too early. Some methods worked better than others.
Methodology
A systematic search of MEDLINE, EMBASE, PUBMED, and Cochrane CENTRAL databases was conducted, followed by frequency-based random-effects network meta-analyses.
Potential Biases
Some studies were funded by pharmaceutical companies, which poses a high risk of bias.
Limitations
The study lacked clinical data on low gestational age and had significant variability in the volume of evidence across comparisons.
Participant Demographics
Infants aged 25–36 weeks, with 21.9% from Europe, 22.3% from North America, and 53.2% from Asia.
Statistical Information
P-Value
0.20 for LMA vs usual care, 0.17 for LISA vs usual care
Confidence Interval
95% CI: 0.09 to 0.42 for LMA, 95% CI: 0.09 to 0.32 for LISA
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website